Quantcast
Last updated on April 16, 2014 at 7:25 EDT

Latest Molecular Imaging Inc. Stories

2013-10-17 16:25:27

ANN ARBOR, Mich., Oct. 17, 2013 /PRNewswire/ -- Molecular Imaging, Inc. (MII), a specialty contract research organization (CRO) that provides multi-modality in vivo imaging services to pharmaceutical and biotechnology companies, as well as academic researchers, announced today it has finalized an agreement to run a new state-of-the-art preclinical imaging center at the Sanford Consortium for Regenerative Medicine (Sanford Consortium) in La Jolla, California. The imaging center...

2013-10-17 12:29:39

ANN ARBOR, Mich. and FREIBURG, Germany, Oct. 17, 2013 /PRNewswire/ -- Molecular Imaging, Inc. ("Molecular Imaging") and Oncotest GmbH ("Oncotest") announced today that they have entered into a collaboration and co-promotion agreement to apply Molecular Imaging's experience and expertise in in-vivo pre-clinical Imaging to the pioneering Patient Derived Xenograft (PDX) work of Oncotest. Under the terms of the agreement both companies will promote the ability to perform PDX pharmacology...

2013-10-11 23:01:17

Molecular Imaging, a specialty contract research organization providing multi-modality preclinical in vivo imaging services to pharmaceutical and biotechnology companies, announces a new white paper to examine new imaging strategies that can facilitate the discovery and clinical use of new therapeutics and diagnostics. Ann Arbor, MI (PRWEB) October 11, 2013 Molecular Imaging, Inc., in collaboration with Cambridge Healthtech Associates™, held a webinar, which took place on September 10,...

2013-09-05 23:23:13

Molecular Imaging, a specialty contract research organization providing multi-modality preclinical in vivo imaging services to pharmaceutical and biotechnology companies, is sponsoring a webinar to examine new imaging strategies that can facilitate the discovery and clinical use of new therapeutics and diagnostics. Ann Arbor, MI (PRWEB) September 05, 2013 The free webinar, which will take place on September 10, 2013 at 11am ET, will feature presentations by Patrick McConville, Chief...

2012-10-04 10:23:52

ANN ARBOR, Mich., Oct. 4, 2012 /PRNewswire/ -- Molecular Imaging, Inc. has expanded its preclinical nuclear medicine program with the addition of Single Photon Emission Computed Tomography (SPECT) imaging. This decision was driven by the growing industry understanding of the value of in vivo molecular imaging throughout the entire drug development process. SPECT is an exciting preclinical modality that allows researchers to 'tag' potential treatments with a variety of radioactive labels to...

2011-12-13 11:59:00

ANN ARBOR, Mich., Dec. 13, 2011 /PRNewswire/ -- Molecular Imaging, Inc. (Molecular Imaging), a specialty contract research organization providing multi-modality preclinical in vivo imaging services to pharmaceutical and biotechnology companies, today announced that it has entered into a licensing agreement with Dana-Farber Cancer Institute to access a substantial number of luciferase-enabled cancer cell lines developed at Dana-Farber. Access to these unique lines dramatically expands...